Toshiba shakes up management team

Article

Michael McLean has been promoted to vice president of full-line sales at Toshiba America Medical Systems. McLean previously managed Toshiba's ultrasound business operations, a position he held about a year. He replaces John Ariatti, who left the Tustin,

Michael McLean has been promoted to vice president of full-line sales at Toshiba America Medical Systems. McLean previously managed Toshiba's ultrasound business operations, a position he held about a year. He replaces John Ariatti, who left the Tustin, CA, company in early November. The reason for his departure was not disclosed.

McLean will oversee North American sales operations for Toshiba's CT, MR, nuclear medicine, and x-ray product lines. The directors of ultrasound sales and marketing will report directly to Masamichi Katsurada, president of TAMS, according to a Toshiba spokesperson. The company also announced the promotion of Joseph Fritz to senior manager of clinical development for all modalities. He formerly managed clinical and luminary site development exclusively for the MRI product group.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.